endolaser machine

Ultrasound Therapy Physical Therapy Machine for OEM Companies

We design and ship Ultrasound Therapy Physical Therapy Machine tailored for OEM partnerships and Companies building robust rehab fleets. I know your procurement teams crave dependable performance, easy integration, and clear value. This unit combines medical-grade ultrasound with versatile settings—1-3 MHz adjustable frequency, continuous and pulsed modes, and energy density up to 2 W/cm2—so you can tailor treatments for musculoskeletal, tendinopathy, and soft-tissue injuries. The compact, ergonomic handpiece, quick-connect transducers, and a simple touch interface minimize training time and downtime. With modular electronics and scalable software, we can support white-labelled branding and firmware customisation to fit your clinics' workflows. Built to meet medical standards, it offers stable operation, durable casing, and reliable uptime in busy clinics. OEM staff and procurement teams often choose this because it reduces equipment clutter while expanding service capabilities. If you’re Companies seeking a trusted partner for high-quality ultrasound therapy, I’m ready to discuss specs, lead times, and volume pricing.

Hot Selling Product

Ultrasound Therapy Physical Therapy Machine Factory Guarantees Peak Performance

For global procurement teams seeking reliable ultrasound therapy equipment for physical therapy clinics, a factory that guarantees peak performance offers more than a device: a proven performance envelope. Precision transducers and modular electronics deliver consistent acoustic output and durable operation under heavy use. Each unit undergoes rigorous validation, including acoustic tests, thermal checks, and software verification, ensuring peak performance from day one. Compliance with international standards and a focus on safety and usability reduce regulatory risk for buyers. Global buyers value predictable supply and full lifecycle support. The facility emphasizes traceable quality, scalable production, and long-term spare parts availability for reliable lead times and minimal downtime. Multilingual interfaces, easy cleaning, and energy-efficient operation boost clinic throughput. Customization of treatment modes and dosing, plus warranty and responsive support, helps buyers maintain peak performance across markets.

{ Ultrasound Therapy Physical Therapy Machine Factory Guarantees Peak Performance}
Model Code Frequency (MHz) Pulse Mode Transducer Area (cm2) Max Output (W) Intensity (W/cm2) Treatment Time (min) Pulse Duration (µs) Pulse Repetition Rate (Hz) Cooling Dimensions (L × W × H cm) Weight (kg) Certifications
US-PT-A1 1.0 Pulsed 5.0 10 0.80 5-15 200 80 Water-cooled 40 × 22 × 35 4.5 CE, ISO 13485
US-PT-A2 3.0 Pulsed 4.0 12 1.00 5-10 150 60 None 42 × 24 × 36 5.2 CE
US-PT-B1 1.0 Continuous 3.5 8 0.90 8-20 N/A N/A Air-cooled 38 × 21 × 34 4.6 CE, FDA
US-PT-C1 0.75 Pulsed 6.0 14 1.20 6-20 180 100 Water-cooled 45 × 26 × 37 6.0 CE, ISO 13485, RoHS
US-PT-D1 1.0 Pulsed 5.5 9 0.95 4-12 250 70 None 39 × 23 × 33 4.8 CE

Related Products

banner1 (3)

Ultrasound Therapy Physical Therapy Machine Now Trending From Concept to Delivery

New Data Dimension: Global Adoption Rate of Ultrasound Therapy Devices by Region (2018-2024)

This explanation accompanies the chart and provides context for the data displayed. The chart tracks adoption rates of ultrasound therapy devices across three major regions from 2018 to 2024. The data indicate a steady acceleration in technology diffusion, with Asia-Pacific exhibiting the fastest growth due to expanding healthcare infrastructure and rising demand for non-invasive physical therapy options. North America leads in early adoption, driven by clinics and rehabilitation centers investing in advanced modalities. Europe follows with a gradual uptick, influenced by standardized treatment protocols and reimbursement considerations. The differences between regions highlight market maturity, access to training, regulatory pathways, and device affordability. By 2024, Asia-Pacific approaches the adoption levels seen in North America, suggesting converging global practice patterns. The line chart also points to external drivers such as aging populations, shifts toward outpatient care, and increasing emphasis on non-invasive therapies. However, limitations exist: the data assume uniform regional weighting and do not capture device variety (different ultrasound intensities, treatment durations, or portable versus fixed systems). The data may rely on reported market figures and clinic surveys, which can underrepresent rural areas or emerging markets. For a more robust interpretation, this visualization should be complemented with clinical outcomes, safety profiles, reimbursement trends, and regulatory changes. Stakeholders can use these insights to prioritize market entry, training programs, and supply chain planning. Ultimately, the chart reflects a global shift toward accessible, non-invasive therapeutic options and highlights opportunities for clinicians, policymakers, and manufacturers to expand patient access while ensuring safety and efficacy.

Top Selling Products